Statistics for Use of half-generation PAMAM dendrimers (G0. 5–G3. 5) with carboxylate end-groups to improve the DACHPtCl2 and 5-FU efficacy as anticancer drugs
Total visits
views | |
---|---|
Use of half-generation PAMAM dendrimers (G0. 5–G3. 5) with carboxylate end-groups to improve the DACHPtCl2 and 5-FU efficacy as anticancer drugs | 30 |
Total visits per month
views | |
---|---|
August 2024 | 1 |
September 2024 | 14 |
October 2024 | 4 |
November 2024 | 1 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
File Visits
views | |
---|---|
Use of half-generation PAMAM dendrimers (G0. 5–G3. 5) with carboxylate end-groups to improve the DACHPtCl2 and 5-FU efficacy as anticancer drugs.pdf(legacy) | 36 |
Top country views
views | |
---|---|
China | 8 |
United States | 6 |
Australia | 5 |
Portugal | 3 |
Ireland | 2 |
Brazil | 1 |
Canada | 1 |
Germany | 1 |
Israel | 1 |
Mongolia | 1 |
Sweden | 1 |